HUBACEK, Jaroslav Alois, Lucie DLOUHA, Ladislav DUŠEK, Ondřej MÁJEK and Vera ADAMKOVA. Apolipoprotein E4 Allele in Subjects with COVID-19. GERONTOLOGY. BASEL: KARGER, 2021, vol. 67, No 3, p. 320-322. ISSN 0304-324X. Available from: https://dx.doi.org/10.1159/000516200.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Apolipoprotein E4 Allele in Subjects with COVID-19
Authors HUBACEK, Jaroslav Alois (203 Czech Republic, guarantor), Lucie DLOUHA (203 Czech Republic), Ladislav DUŠEK (203 Czech Republic, belonging to the institution), Ondřej MÁJEK (203 Czech Republic, belonging to the institution) and Vera ADAMKOVA (203 Czech Republic).
Edition GERONTOLOGY, BASEL, KARGER, 2021, 0304-324X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30227 Geriatrics and gerontology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.597
RIV identification code RIV/00216224:14110/21:00121856
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1159/000516200
UT WoS 000659535900009
Keywords in English COVID-19; Apolipoprotein E4 Allele
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 28/6/2021 13:54.
Abstract
We recently read with keen interest a study by Del Ser et al., who suggest that carriers of APOE4 alleles come under increased risk of mild to moderate symptoms of coronavirus disease 2019 (COVID-19) during SARSCoV-2 infection. COVID-19 disease occurs as a consequence of infection with the RNA coronavirus SARSCoV-2. First reported in Wuhan, China, in December 2019, COVID-19 has since spread rapidly and has become a global pandemic. Although highly contagious, the virus is nonetheless associated with relatively low mortality when compared with other coronavirus infections (MERS or SARS).
PrintDisplayed: 23/7/2024 21:11